Your browser doesn't support javascript.
loading
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
Shi, Yuankai; Lei, Kaijian; Jia, Yuming; Ni, Bingqiang; He, Zhiyong; Bi, Minghong; Wang, Xicheng; Shi, Jianhua; Zhou, Ming; Sun, Qian; Wang, Guolei; Chen, Dongji; Shu, Yongqian; Liu, Lianke; Guo, Zhongliang; Liu, Yong; Yang, Junquan; Wang, Ke; Xiao, Ke; Wu, Lin; Yi, Tienan; Sun, Debin; Kang, Mafei; Ma, Tianjiang; Mao, Yimin; Shi, Jinsheng; Tang, Tiegang; Wang, Yan; Xing, Puyuan; Lv, Dongqing; Liao, Wangjun; Luo, Zhiguo; Wang, Bin; Wu, Xiaohong; Zhu, Xiaoli; Han, Shuhua; Guo, Qisen; Liu, Rongyu; Lu, Zhiwei; Zhang, Jianyong; Fang, Jian; Hu, Changlu; Ji, Yinghua; Liu, Guolong; Lu, Hong; Wu, Dedong; Zhang, Junhong; Zhu, Shuyang; Liu, Zheng; Qiu, Wensheng.
Affiliation
  • Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, 100021, P. R. China.
  • Lei K; Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, 644000, P. R. China.
  • Jia Y; Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, 644000, P. R. China.
  • Ni B; Department of Oncology, Liuzhou People's Hospital, Liuzhou, Guangxi, 545006, P. R. China.
  • He Z; Department of Thoracic Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, 350014, P. R. China.
  • Bi M; Oncology Department, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233030, P. R. China.
  • Wang X; Department of Oncology, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510030, P. R. China.
  • Shi J; Department of Internal medicine, Linyi Cancer Hospital, Linyi, Shandong, 276002, P. R. China.
  • Zhou M; Department of Thoracic Surgery, the Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510095, P. R. China.
  • Sun Q; Department of Internal Medicine-Oncology/Department of thoracic oncology, Henan Chest Hospital, Zhengzhou, Henan, 450003, P. R. China.
  • Wang G; Department of Internal Medicine-Oncology/Department of thoracic oncology, Henan Chest Hospital, Zhengzhou, Henan, 450003, P. R. China.
  • Chen D; The Second Department of Radiotherapy, Wuwei Cancer Hospital of Gansu Province, Wuwei, Gansu, 730000, P. R. China.
  • Shu Y; Department of Oncology, the People's Hospital of Jiangsu Province, Nanjing, Jiangsu, 210000, P. R. China.
  • Liu L; Department of Oncology, the People's Hospital of Jiangsu Province, Nanjing, Jiangsu, 210000, P. R. China.
  • Guo Z; Respiratory Medicine Department, Shanghai East Hospital, Shanghai, 200120, P. R. China.
  • Liu Y; The Second Department of Internal Medicine-Oncology, Xuzhou Central Hospital, Xuzhou, Jiangsu, 221009, P. R. China.
  • Yang J; Oncology Department, Tangshan People's Hospital, Tangshan, Hebei, 063001, P. R. China.
  • Wang K; Respiratory Medicine Department, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
  • Xiao K; Thoracic Surgery, the Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515051, P. R. China.
  • Wu L; Internal Medicine-Oncology, Hunan Cancer Hospital, Changsha, Hunan, 410013, P. R. China.
  • Yi T; Department of Oncology, Xiangyang Central Hospital, Xiangyang, Hubei, 441021, P. R. China.
  • Sun D; Respiratory Department, Lishui Central Hospital, Lishui, Zhejiang, 323000, P. R. China.
  • Kang M; Oncology Department, The Affiliated Hospital of Guilin Medical College, Guilin, Guangxi, 541001, P. R. China.
  • Ma T; Internal Medicine-Oncology, Luohe Central Hospital, Luohe, Henan, 462000, P. R. China.
  • Mao Y; Respiratory Department, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, 471003, P. R. China.
  • Shi J; Oncology Department, Cangzhou People's Hospital, Cangzhou, Hebei, 061000, P. R. China.
  • Tang T; Oncology Department, Xiangtan Central Hospital, Xiangtan, Hunan, 411100, P. R. China.
  • Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, 100021, P. R. China.
  • Xing P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, 100021, P. R. China.
  • Lv D; Respiratory Department, Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, 317000, P. R. China.
  • Liao W; Department of Oncology, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, P. R. China.
  • Luo Z; Department of Oncology, Taihe Hospital of Shiyan City, Shiyan, Hubei, 442000, P. R. China.
  • Wang B; Respiratory Department, Huzhou Central Hospital, Huzhou, Zhejiang, 313003, P. R. China.
  • Wu X; Internal Medicine-Oncology, the Fourth People's Hospital of Wuxi City, Wuxi, Jiangsu, 214062, P. R. China.
  • Zhu X; Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, P. R. China.
  • Han S; Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, Jiangsu, 210009, P. R. China.
  • Guo Q; The Second Department of Internal Medicine, Shandong Cancer Hospital, Jinan, Shandong, 250117, P. R. China.
  • Liu R; Respiratory Department, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, P. R. China.
  • Lu Z; Respiratory Department, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241001, P. R. China.
  • Zhang J; The Second Department of Respiratory Medicine, the Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, 563099, P. R. China.
  • Fang J; The Second Department of thoracic oncology, Beijing Cancer Hospital, Beijing, 100142, P. R. China.
  • Hu C; Department of Oncology, Anhui Cancer Hospital, Hefei, Anhui, 233004, P. R. China.
  • Ji Y; Oncology Department, the First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, 453100, P. R. China.
  • Liu G; Department of Oncology, the First People's Hospital of Guangzhou, Guangzhou, Guangdong, 510180, P. R. China.
  • Lu H; Oncology Department, Huaihe Hospital of Henan University, Kaifeng, Henan, 475000, P. R. China.
  • Wu D; Department of Oncology and Hematology, The First People's Hospital of Zhengzhou, Zhengzhou, Henan, 450004, P. R. China.
  • Zhang J; Oncology Department, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, P. R. China.
  • Zhu S; Respiratory Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, P. R. China.
  • Liu Z; The Third Department of Oncology, Handan Central Hospital, Handan, Hebei, 056001, P. R. China.
  • Qiu W; Oncology Department, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266011, P. R. China.
Cancer Commun (Lond) ; 41(9): 889-903, 2021 09.
Article in En | MEDLINE | ID: mdl-34184418
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Biosimilar Pharmaceuticals / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Commun (Lond) Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Biosimilar Pharmaceuticals / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Country/Region as subject: Asia Language: En Journal: Cancer Commun (Lond) Year: 2021 Type: Article